01053-X/asset/826330f0-5581-4d6d-8f45-2192fe6ac242/main.assets/gr2_lrg.jpg)
retatrutide glp-1 gip glucagon agonist Retatrutide, a GIP, and receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA Retatrutide: The triple agonist powering
Description
Who are GLP-1 medications suitable for
Weight loss improves insulin sensitivity, reduces androgen levels, and can restore ovulatory function
The findings from a large, cardiovascular event-driven safety trial, which compares tirzepatide and dulaglutide among 12,500 participants in the SURPASS-CVOT trial, are expected to be published in the near future
GLP-1 medications are typically used as a long-term treatment for weight management
Treatment of sporadic inclusion body myositis with bimagrumab
Frontiers in Pharmacology, 15 , 1416985
